These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6745319)

  • 1. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.
    Heym J; Rasmussen K; Jacobs BL
    Eur J Pharmacol; 1984 May; 101(1-2):57-68. PubMed ID: 6745319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats.
    Trulson ME
    Pharmacol Biochem Behav; 1986 Feb; 24(2):351-7. PubMed ID: 3952126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological effects of hallucinogens on serotonergic neuronal systems.
    McCall RB
    Neurosci Biobehav Rev; 1982; 6(4):509-14. PubMed ID: 7177511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
    Trulson ME; Preussler DW; Trulson VM
    J Pharmacol Exp Ther; 1984 Jan; 228(1):94-102. PubMed ID: 6694110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.
    White FJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):365-79. PubMed ID: 3952127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
    Helsley S; Fiorella D; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a non-hallucinogenic ergoline derivative, lisuride, in an animal behavior model for hallucinogens.
    Marini JL; Jacobs BL; Sheard MH; Trulson ME
    Psychopharmacology (Berl); 1981; 73(4):328-31. PubMed ID: 6789353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic and dopaminergic effects of yawning in the cat.
    Marini JL
    Pharmacol Biochem Behav; 1981 Nov; 15(5):711-5. PubMed ID: 7312907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.